Impact of the Major Histocompatibility Complex class I peptide repertoire on Natural Killer cell function
Impact of the Major Histocompatibility Complex class I peptide repertoire on Natural Killer cell function
Background: Natural Killer (NK) cell activation requires the integration of inhibitory and activating signalling. Inhibitory signals are determined by members of the KIR family, which have MHC class I ligands. Peptide antagonism of MHC class I provides an alternative mechanism for loss of inhibition of KIR2DL2/3-positive NK cells. This occurs when a weak KIR binding peptide disrupts the inhibitory signalling of a strong binding peptide. Peptide antagonism has been defined only for HLA-C*0102, endogenously expressed in TAP-deficient cells, using a peptide variant of VAPWNSLSL (VAPWNSDAL and VAPWNSDYL), therefore it may be a unique property of HLA-C*0102 or more general finding.
Hypothesis: We hypothesize that small changes in MHC-I peptide repertoire can impact on NK cell activation and that additional peptides can antagonise inhibitory KIR can be discovered.
Results: 721.221 cells were transfected with HLA-C*0304 and ICP47 used for peptide loading and as target cells in CD107a assays. We studied previously described position 8 (P8) derivatives and also generated novel P7 derivatives of the endogenously processed peptide GAVDPLLAL. In contrast to our observations for HLA-C*0102, arginine at P7 triggered stronger inhibition than phenylalanine. L7D did not inhibit KIR2DL2/3-positive NK cells. However it did antagonise inhibition by L7R in CD107a assays. I used peptide elution and HPLC analysis to demonstrate that peptide antagonism was not related to displacement of L7R or L7F by LD7. In a study of the immunopeptidome of Hepatitis C virus expressing cells expressing HLAC*0102 were generated to study its peptide repertoire and to identify potential NK activating or inhibitory peptides. I identified that the peptide repertoire of HLA-C was preferentially altered in comparison to HLA-A. To improve our methods for studying the influence of peptides on NK cell, I developed a Granzyme B assay based on HPLC technology. This showed that it is possible to perform a functional assay using NK lines with low backgrounds, however it was not robust enough to detect small differences in peptides.
Conlcusions: Peptide antagonism is a generalizable phenomenon and it appears that HLA-C alleles has become specialised to NK cells.
University of Southampton
Mbiribindi Nvunabandi, Berenice
7517597a-8f04-4c44-937d-c59c7843e43f
December 2016
Mbiribindi Nvunabandi, Berenice
7517597a-8f04-4c44-937d-c59c7843e43f
Khakoo, Salim
6c16d2f5-ae80-4d9b-9100-6bfb34ad0273
Mccormick, Christopher
0fce14bf-2f67-4d08-991f-114dd1e7f0bd
Mbiribindi Nvunabandi, Berenice
(2016)
Impact of the Major Histocompatibility Complex class I peptide repertoire on Natural Killer cell function.
University of Southampton, Doctoral Thesis, 233pp.
Record type:
Thesis
(Doctoral)
Abstract
Background: Natural Killer (NK) cell activation requires the integration of inhibitory and activating signalling. Inhibitory signals are determined by members of the KIR family, which have MHC class I ligands. Peptide antagonism of MHC class I provides an alternative mechanism for loss of inhibition of KIR2DL2/3-positive NK cells. This occurs when a weak KIR binding peptide disrupts the inhibitory signalling of a strong binding peptide. Peptide antagonism has been defined only for HLA-C*0102, endogenously expressed in TAP-deficient cells, using a peptide variant of VAPWNSLSL (VAPWNSDAL and VAPWNSDYL), therefore it may be a unique property of HLA-C*0102 or more general finding.
Hypothesis: We hypothesize that small changes in MHC-I peptide repertoire can impact on NK cell activation and that additional peptides can antagonise inhibitory KIR can be discovered.
Results: 721.221 cells were transfected with HLA-C*0304 and ICP47 used for peptide loading and as target cells in CD107a assays. We studied previously described position 8 (P8) derivatives and also generated novel P7 derivatives of the endogenously processed peptide GAVDPLLAL. In contrast to our observations for HLA-C*0102, arginine at P7 triggered stronger inhibition than phenylalanine. L7D did not inhibit KIR2DL2/3-positive NK cells. However it did antagonise inhibition by L7R in CD107a assays. I used peptide elution and HPLC analysis to demonstrate that peptide antagonism was not related to displacement of L7R or L7F by LD7. In a study of the immunopeptidome of Hepatitis C virus expressing cells expressing HLAC*0102 were generated to study its peptide repertoire and to identify potential NK activating or inhibitory peptides. I identified that the peptide repertoire of HLA-C was preferentially altered in comparison to HLA-A. To improve our methods for studying the influence of peptides on NK cell, I developed a Granzyme B assay based on HPLC technology. This showed that it is possible to perform a functional assay using NK lines with low backgrounds, however it was not robust enough to detect small differences in peptides.
Conlcusions: Peptide antagonism is a generalizable phenomenon and it appears that HLA-C alleles has become specialised to NK cells.
Text
B Mbiribindi eThesis
- Version of Record
More information
Published date: December 2016
Identifiers
Local EPrints ID: 435887
URI: http://eprints.soton.ac.uk/id/eprint/435887
PURE UUID: 1951f97b-263e-428b-a0a6-994bbebb00db
Catalogue record
Date deposited: 22 Nov 2019 17:30
Last modified: 23 Nov 2019 01:34
Export record
Contributors
Author:
Berenice Mbiribindi Nvunabandi
University divisions
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics